Brokerages Set Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) PT at $10.38

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are currently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $10.3750.

Several equities analysts have issued reports on AVAH shares. Royal Bank Of Canada cut their price objective on Aveanna Healthcare from $11.00 to $9.00 and set a “sector perform” rating for the company in a research report on Monday, March 23rd. Raymond James Financial upgraded Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price on the stock in a report on Friday, March 20th. Barclays cut their price target on Aveanna Healthcare from $11.00 to $9.50 and set an “overweight” rating for the company in a report on Wednesday, March 25th. William Blair assumed coverage on shares of Aveanna Healthcare in a research report on Monday, December 8th. They set an “outperform” rating on the stock. Finally, Truist Financial decreased their price objective on shares of Aveanna Healthcare from $10.00 to $9.00 and set a “hold” rating on the stock in a report on Friday, March 20th.

Insider Activity at Aveanna Healthcare

In related news, insider Patrick A. Cunningham sold 18,436 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $132,923.56. Following the completion of the transaction, the insider owned 337,755 shares in the company, valued at $2,435,213.55. The trade was a 5.18% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Jeff Shaner sold 173,225 shares of the company’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $1,248,952.25. Following the transaction, the chief executive officer directly owned 2,650,892 shares in the company, valued at approximately $19,112,931.32. This represents a 6.13% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 738,957 shares of company stock valued at $5,458,175 over the last ninety days. Company insiders own 7.80% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd lifted its stake in shares of Aveanna Healthcare by 252.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after acquiring an additional 2,400 shares during the period. Invesco Ltd. increased its position in Aveanna Healthcare by 1,001.5% in the fourth quarter. Invesco Ltd. now owns 360,464 shares of the company’s stock worth $2,945,000 after purchasing an additional 327,738 shares during the period. Mackenzie Financial Corp raised its holdings in Aveanna Healthcare by 12.7% during the 4th quarter. Mackenzie Financial Corp now owns 216,200 shares of the company’s stock worth $1,810,000 after purchasing an additional 24,447 shares during the last quarter. Zimmer Partners LP bought a new stake in Aveanna Healthcare during the 4th quarter worth about $6,189,000. Finally, Voloridge Investment Management LLC acquired a new position in Aveanna Healthcare during the 4th quarter valued at about $1,915,000. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Price Performance

Shares of AVAH opened at $6.38 on Friday. The company has a market capitalization of $1.39 billion, a P/E ratio of 6.25 and a beta of 2.08. Aveanna Healthcare has a one year low of $3.73 and a one year high of $10.32. The business’s 50 day simple moving average is $7.32 and its 200-day simple moving average is $8.37. The company has a debt-to-equity ratio of 6.62, a current ratio of 1.32 and a quick ratio of 1.32.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.